AADE Resources and Communications

AADE in Practice Articles

July 2015 
“From Research to Practice: A Review of ‘Update on Health Literacy and Diabetes’”
by Carla Cox, PHD, RD, CDE and Anna Fletcher, MS, BSN, BA, RN, CDE.
While pointing out that studies suggest that individuals with diabetes who have poor literacy are at risk for poor outcomes, the authors discuss evidence that these barriers can be managed and even overcome in some cases. They note that importance of one on one education as opposed to group education for these patients. (PCOR)

March 2015
“Pharmacy Medication Therapy Management: A Critical Piece of the Diabetes Management Puzzle” by Tina M Claypool, PharmD, CDE. Describes a pharmacist-led medication therapy management (MTM) program for patients with diabetes in Kentucky which entails a detailed review of a patient’s medication use (identification of adverse events, medication interaction, medication duplication, medication compliance, etc) and a patient centered interview. After these individualized assessments, the pharmacist provides recommendations to the patient and their healthcare provider as needed. Lower A1C, improved medication adherence, and other outcomes demonstrate the efficacy of the program. (PCOR, CER)

January 2015
“Breaking Down Barriers: A Second Attempt at Inhaled Insulin” by Steven Sparks PharmD and Jennifer Goldman-Levine, PharmD, CDE. Describes the newly available inhaled insulin medication Afrezza as an alternative to subcutaneous injection of bolus insulin for diabetes patients taking basal bolus insulin. The report also summarizes findings of comparator clinical trials that found Afrezza noninferior to subcutaneous bolus insulin. The authors report that Afrezza may overcome barriers to medication compliance in patients with needle phobias, fear of weight gain, or fear of hypoglycemia.  (PCOR, CER)

January 2015
“Glucagon-Like Peptide Receptor Agonists: A Viable Addition to Basal-Bolus Therapy in Type 2 Diabetes” by Tommy Johnson, PharmD, CDE et al. An informal study was conducted to see if adding the GLP-1 agonist liraglutide to the treatment regimens of patients with type 2 diabetes receiving basal bolus insulin would lower A1C and weight and allow for a lower dose of insulin. Results are reported for six patients most of whom lost weight, were able to lower their insulin dose, and had lower A1C values. The authors conclude that adding liraglutide may improve outcomes for type 2 diabetes patients taking basal bolus insulin. (CER)

November 2014
“Is it Really no Big Deal? Suggestions for Providers from Patients with Type 2 Diabetes” by Sondra Bedwell, PhD, RN. This report relates the results of a qualitative research study into the patient experience of persons with type 2 diabetes. Fourteen patients participated, all of whom were diagnosed with T2D within the past year. The findings support the view that individualization is key to effective diabetes self-management education due to myriad differences among patients. (PCOR)

September 2014
“The Diabetes Patient-Provider Relationship: 5 Ways to Make it Even Stronger” by Quinn Nystrom. Effective communication between healthcare providers and patients is key to individualization of diabetes management. This article describes five ways to improve lines of communications so that patient preferences and needs are fully understood, allowing for patient-centered care. (PCOR)

July 2014
“Opportunities and Strategies for Meaningful Engagement with Women with Gestational Diabetes Mellitus” by Amber Mcculloch, MA and Ruth Lipman, PhD. Discussing prevalence of gestational diabetes and the health risks this poses to women and their unborn children, the authors point out the need to increase awareness and improve adherence to postpartum screening for type 2 diabetes in these patients; recommendations that may improve adherence to screening these patients for type 2 diabetes are provided.  (PCOR)

July 2014
“Insulin Pens – Some Points to be Made” by Jerry Meece RPH, CDE, FACA, FAADE. Discusses how use of insulin pens instead of vial/syringe delivery of insulin improves patient compliance with insulin regimen. Reasons cited include less pain, ease of use, discreetness and social acceptance. Also notes that by improving compliance, insulin pen use reduces costs associated with complications of diabetes. (CER)

March 2014
“Evaluating Insulin Formulations on Comparing Effectiveness and Patient-Centered Outcomes” by Anna Fletcher, RN, CDE and Carla Cox, PhD, RD, CDE. Discusses how to identify insulin medications that best serve an individual patient’s needs and preferences through consideration of factors that include effectiveness, potential harms, potential benefits and cost. Compares premixed formulations of intermediate and rapid acting insulin (PMIA) with basal bolus therapy (BBT) where rapid and long acting insulins are administered separately. (PCOR, CER)

January 2014
“Blood Glucose Monitoring: Overcoming the Obstacles” by Tamara Swigert, MSN, RN, CDE.  Noting the critical importance of patient compliance with blood glucose monitoring for successful diabetes management, the author identifies seven obstacles to compliance and how diabetes educators can help their patients overcome them. Obstacles include pain, cost, and not recognizing the importance of monitoring.

Webinars

“Patient-Centered Care: The diabetes education and support algorithm” Presented live by Joan Bardsley, RN, MBA, CDE, FAADE and Margaret Powers, PhD, CDE, RDN on October 21st 2015. The purpose of this activity was to give diabetes educators a better understanding of the DSME/S position statement and its potential use in a variety of health care settings. (PCOR)

 “Medication Effectiveness: How do type 2 meds compare?” Presented live by Joshua J. Neumiller, PharmD, CDE, FASCP on September 29th, 2015. The purpose of this activity was to help the diabetes educator to better meet the educational and counseling needs of patients with T2DM through a better understanding of medications and comparative effectiveness research.  (CER)

 “Guidelines for Medication Management of Type 2 Diabetes—2015” Presented live by Christie Schumacher, PharmD, BCPS, BC-ADM, CDE on May 20th 2015. The purpose of this activity was to enable the learner to differentiate between the different medications available for type 2 diabetes, including efficacies and side effects. (CER)

“Medication-related Weight Gain in Diabetes”
Presented live by Megan Kildow, PharmD, BCACP, CDE on March 4th, 2015. This activity enabled diabetes educators to better understand the association of weight gain and development of diabetes, compare and contrast diabetes therapy options and their effects on weight, and apply this knowledge to patient care. (PCOR, CER)

“Diabetic Macular Edema Prevention and Treatment”
Presented live by Szilárd Kiss, MD on December 10, 2014. The purpose of this activity was to teach diabetes educators about the diagnosis, prevention and available treatment options for diabetic macular edema (CER)

“The Diabetic Foot Ulcer: Prevention, Treatment and Patient Impact”
Presented live by Ryan Crews, MS, CCRP, Adam Fleisher, DPM, MPH, and Stephanie Wu, DPM, MS on December 3, 2014. This webinar provided diabetes educators with needed knowledge regarding diabetic foot ulcers (DFU) and the challenges of treating them. After the activity, learners are enabled to list commonly employed treatments for DFU and recognize patient centered considerations for treating DFU. (PCOR, CER) 

“Diabetes Care Across Healthcare Transitions”
Presented live by Christie Schumacher, PharmD, BCPS, BC-ADM, CDE on November 25, 2014. Diabetes educators are responsible for ensuring that patients continue to receive the best possible care when transitioning between different settings. This webinar's purpose was to provide diabetes educators with increased knowledge about the different patient care settings and the communication needed to ensure self-care and adherence. (PCOR)

“Guidelines for Medication Management in Patients with Type 2 Diabetes”
Presented live by Christie Schumacher, PharmD, BCPS, BC-ADM, CDE on June 11, 2014. The webinar covered covers how the different blood glucose lowering agents work, and how they can fit into patients' therapy to achieve better outcomes. (CER)

“Obesity Series, Part III: Pharmacotherapeutic Approaches to the Management of Obesity”
Presented live by Eva Vivian, PharmD, MS, CDE, BC-ADM on May 7, 2014. The purpose of this activity was to enable the learner to become more knowledgeable about pharmacologic agents currently available for the management of obesity. (CER)

“Applying the Essentials of Health Literacy to Your Practice”
Presented live by Marie Frazzitta DNP, FNP-c, CDE on February 4th 2014. The purpose of this educational activity was to enable learners to be able to improve their knowledge of health literacy and incorporate the tenets of health literacy and effective communication techniques into their daily practice. (PCOR)

In This Section

Research